Skip to main content Start of content

INDU Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at

Previous day publication Next day publication

Minutes of Proceedings

43rd Parliament, 2nd Session
Meeting 17
Tuesday, February 16, 2021, 11:04 a.m. to 12:58 p.m.
Sherry Romanado, Chair (Liberal)

Library of Parliament
• Sarah Lemelin-Bellerose, Analyst
• Francis Lord, Analyst
• Andrew Casey, President and Chief Executive Officer
• Volker Gerdts, Director and Chief Executive Officer
Providence Therapeutics
• Ken Hughes, Chair of the Board
• Brad Sorenson, Chief Executive Officer
As an individual
• Amir Attaran, Professor, Faculty of Law and School of Epidemiology and Public Health, University of Ottawa
• Alain Lamarre, Full professor
• Joel Lexchin, Associate Professor, Department of Family and Community Medicine, Emergency Medicine Division, University of Toronto
Pursuant to Standing Order 108(2) and the motion adopted by the committee on Tuesday, December 1, 2020, the committee resumed its study of domestic manufacturing capacity for a COVID-19 vaccine.

The witnesses made statements and answered questions.

At 12:58 p.m., the committee adjourned to the call of the Chair.

Michael MacPherson
Clerk of the Committee